Latest News of MBIO
How did Arm and Qualcomm's 'symbiotic' partnership go south?
Arm Holdings has notified Qualcomm of termination for their license agreement. Moor Insights & Strategy founder Patrick Moorhead discusses the dispute's impact on the companies' relationship and the p...
Alex Hall and Nik Richie toast to Cymbiotika co-founder Durana Elmi's cover
Newsweek's entertainment gossip features a glamorous event at The Mayor's Table in Newport Beach celebrating Durana Elmi's magazine cover debut. Notable guests included Alex Hall and NFL quarterback M...
Mustang Bio, Inc. (MBIO) Stock Price, News, Quote & History
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focusing on developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases....
-
Mustang Bio, Inc. (MBIO) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 5 months agoMustang Bio reports positive results from Phase 1/2 trial of MB-106 CAR-T therapy for Waldenstrom Macroglobulinemia. 90% response rate with durable responses, including one patient in remission at 31 ...